Transgene Biotek informs about outcome of AGM

01 Jan 2024 Evaluate
Transgene Biotek has informed that in accordance with the circulars of Ministry of Corporate Affairs, Securities and Exchange Board of India (SEBI) and applicable provisions of the Companies Act, 2013 and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), the 33rd AGM of the Company was held on 30th December, 2023 through Video Conference (VC) / Other Audio Video Means (OAVM). As per the requirements of the Companies Act, 2013, Listing Regulations and the relevant Circulars issued by the Ministry of Corporate Affairs, the Company had provided remote evoting facility to its Shareholders for voting on the businesses transacted at the AGM. The Company had appointed Geeta Serwani, Practising Company Secretary, as the Scrutiniser for remote e-voting and e-voting at the AGM. As per the Scrutiniser’s Report, all Resolutions as set out in the Notice of 33rd AGM have been duly approved by the Shareholders and have been passed by majority. The Scrutiniser’s Report is enclosed as Annexure 1. 

The above information is a part of company’s filings submitted to BSE.

Transgene Biotek Share Price

7.11 -0.37 (-4.95%)
26-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Aster DM Healthcare 359.00
Apollo Hospital Ent. 6260.00
Max Healthcare Inst 802.00
Narayana Hrudayalay 1280.00
Global Health 1438.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.